2021年至2028年免疫组织化学市场将以7.4%的复合年增长率增长,达到35.8531亿美元

  • Report Code : TIPRE00006184
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 259
Buy Now

[研究报告]免疫组化市场预计将从 2021 年的 217161 万美元增至 2028 年的 358531 万美元;预计 2021 年至 2028 年复合年增长率为 7.4%。

市场洞察和分析师观点:< /u>

免疫组织化学 (IHC) 是一种使用基于显微镜技术来观察组织样本中的细胞成分(例如蛋白质或其他大分子)的工具。它是医疗保健和病理学中常用的工具。 IHC 广泛用于研究应用,其中分析感兴趣的分子,以在细胞、分子或组织水平上研究它们在健康和患病细胞和组织中的作用。有多种 IHC 方法可用于定位抗原。 IHC 主要考虑样本类型和检测灵敏度等参数。全球免疫组化 ihc 市场规模预计将从 2021 年的 217.161 亿美元增至 2028 年的 35.8531 亿美元。预计 2021-2028 年该市场将以 7.4% 的复合年增长率增长。

增长动力和挑战:

慢性病发病率上升和传染病

免疫组织化学(IHC)是指单克隆和多克隆抗体用于特定疾病抗原的组织测定和分布的重要应用。它主要用于检测登革热、肝炎、人类免疫缺陷病毒(HIV)等多种传染病。肥胖、癌症、糖尿病、心脏病和中风等慢性疾病也被认为是免疫组织化学的主要应用,有助于诊断这些疾病。

根据联合国艾滋病毒/艾滋病联合规划署 (UNAIDS) 的数据,2020 年全球约有 3760 万人感染艾滋病毒。其中,3590 万人是成年人,170 万人是儿童(15 岁以下)。 2020 年,全球估计有 150 万人感染艾滋病毒。根据艾滋病毒和艾滋病组织 (AVERT) 的数据,2018 年,美国有 110 万居民感染艾滋病毒,而亚太地区有 520 万艾滋病毒感染者。根据欧洲疾病预防控制中心的数据,2018 年欧洲约有 200 万人感染了艾滋病毒。

糖尿病在全球老年人口中流行率很高。超重和肥胖人群中糖尿病的患病率更高。根据美国疾病控制与预防中心 (CDC) 2017 年发布的数据,约有 3030 万人患有糖尿病,占美国人口的 94%。其中,约2310万人被诊断患有糖尿病,而约720万人没有接受适当的诊断程序。

发达国家的肥胖率也在迅速增加作为全球发展中经济体。不健康的生活方式和久坐的生活等因素是肥胖人数增加的主要原因。根据美国国家健康统计中心(NCHS)公布的数据,2015年至2016年间,肥胖患病率预计约为39.8%,影响约9330万美国成年人。肥胖发生率明显偏高中年人(42.7%)与年轻人(35.7%)相比。美国肥胖人数的增加也导致了医疗保健支出的增加。

心血管疾病(CVD)包括脑血管疾病、风湿性心脏病、冠心病疾病和其他状况。它是全世界发病和死亡的最重要原因。根据2017年欧洲心血管疾病统计数据,每年心血管疾病导致390万人死亡,欧盟(EU)超过180万人死亡。 CVD 占欧洲死亡人数的 45.0%,占欧盟死亡人数的 37.0% 此外,根据美国心脏协会 (AHA) 2019 年的统计数据,美国有 1.215 亿成年人,约占美国成年人口的一半。心血管疾病。

此外,全世界癌症发病率和死亡率不断上升,使癌症成为主要死亡原因。根据世界卫生组织2018年的数据,全球约有960万人死于癌症。

此外,美国国家癌症研究所预测,2018年约有1,735,350例新发癌症同样,在中国,根据世界卫生组织公布的数据,2018 年新增癌症病例约 430 万,癌症死亡人数达 290 万。传染病预计将在世界各地产生对免疫测定测试的需求。

战略见解

< /p>

市场限制

与免疫组织化学相关的限制< /u>

免疫组织化学利用抗体的特异性来检测组织或细胞中的靶分子。此外,IHC 也被证明是毒理学研究中的一项强大技术。然而,与该技术的特异性和准确性相关的一些限制在一定程度上限制了其采用。

试剂缺乏特异性是一个比被普遍认可。缺乏特异性可能会导致资源和时间的巨大浪费。此外,该技术的应用还受到抗体物理局限性的限制。此外,如果染色研究设计没有经过仔细构思和控制,免疫组织化学可能会产生误导。

尽管该系统是检测给定标记表达的最简单、最方便的方法但由于灵敏度不足、每个一抗需要单独与荧光团或酶缀合以及染色问题等限制,它在临床和研究应用中并未得到有效应用。因此,与 IHC 技术相关的局限性可能会在一定程度上阻碍市场增长。

报告细分和范围:

“全球免疫组织化学市场”根据应用程序、产品、最终用户和地理位置进行细分。全球免疫组织化学市场根据产品分为抗体、设备、试剂和试剂盒。全球免疫组织化学市场根据应用分为诊断和药物测试。 2021年,诊断领域可能会占据最大的市场份额。全球免疫组织化学市场根据最终用户分为医院和医院。诊断实验室、研究机构等。免疫组织化学市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国、亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

细分分析:

根据产品,分为抗体、设备、试剂和试剂盒。抗体细分市场可能会在 2021 年占据最大的市场份额。此外,由于试剂细分市场的现有使用量、高消费量和产品创新,预计在预测期内其复合年增长率最高。试剂使研究人员能够以卓越的水平对组织和测定进行深入分析。免疫组织化学中常用的试剂包括组织学染色剂、封闭剂和染色剂。固定试剂、显色底物、稳定剂、溶剂和蛋白水解酶等。 Thermo Fisher Scientific Inc.、Abcam plc.、Enzo Life Sciences, Inc.、QIAGEN、Bio-Rad Laboratories 是该领域的一些主要参与者。新型试剂还提高了精确和准确的数据量和质量的规格,以及卓越的服务结果试剂的现有使用、不断增长的研发支出、不断增长的政府支持和技术创新是预计将加强数据增长的因素之一。预测期内的试剂细分市场。

免疫组织化学市场分析(按产品) – 2021年和2028年

全球免疫组织化学市场,基于应用分为诊断和药物测试。 2021年,诊断领域可能会占据最大的市场份额。此外,由于全球各种医疗状况的检测和诊断的增加,预计该细分市场的需求在 2021 年至 2028 年期间将以最快的复合年增长率增长。通过免疫组织化学对癌症、自身免疫性疾病、感染性疾病、肾病等各种慢性疾病的诊断已变得十分高效。使用抗体、试剂、染料和其他分子诊断工具可以在更短的时间内快速获得重要信息。

免疫组织化学的使用可以准确地解释诊断并为临床医生提供帮助用最好的治疗方法进行治疗。免疫组织化学的其他优点包括识别疾病的遗传和分子原因,这可能有助于提供最佳的治疗方法和患者护理。它还有助于治疗应用,能够根据免疫学结果评估治疗技术。

此外,免疫组织化学技术比其他医学诊断技术更具成本效益。与医学诊断相比,免疫组织化学诊断花费数百美元。此外,技术进步使得抗体和分子诊断工具变得容易获得。因此,由于免疫组织化学在疾病诊断方面的优势,预计市场在预测期内可能呈指数级增长。全球免疫组织化学市场根据最终用户分为医院和医院。诊断实验室、研究机构等。 2021年,医院&按最终用户计算,诊断实验室部分可能占据最大的市场份额。此外,由于传染病、癌症和自身免疫性疾病患病率的上升,预计该领域在未来几年还将以最快的速度增长。这些疾病病例的增加预计将推动对其诊断的需求,从而导致该细分市场的增长。医院是任何国家医疗保健系统的重要组成部分之一。技术进步帮助医院诊断和治疗各种疾病,如心脏、神经、艾滋病毒、肝炎、肿瘤等。该医院为患有各种疾病和病症的患者提供广泛的医疗保健和医疗服务。如今,医院为患者提供更好的服务。通常,此类医院提供针对多种适应症的诊断和治疗服务。大量患者入院接受手术,同时还有几名患者前来接受诊断治疗。在收治的患者中,大多数人已经患有某些疾病。因此,为了实时监测和控制他们的健康状况,大多数医院都设有临床诊断实验室。因此,医院为免疫组织化学市场贡献了巨大的市场份额,预计在预测期内将继续保持这一趋势。

诊断中心提供组织、细胞和组织的完整分析。提供全面诊断的体液,以确保为患者提供最高质量的服务和护理。需要。诊断中心拥有生化分析仪、血液分析仪、诊断试剂盒、PCR、凝胶电泳等现代化诊断病理设备和仪器。病理诊断中心可以让患者在几小时到几天内收到现场病理学家的详细报告。例如,美国控股实验室公司成立于 1978 年,是提供全套病理和诊断服务的领先诊断实验室之一。 LabCorp 因优质和富有同情心的患者护理而赢得了独特的声誉。病理技术的进步可以在较短的周转时间内提供快速、准确的结果,这可能会推动病理学和诊断中心领域在预测年内的增长。

免疫组化市场分析、区域分析:

根据地理位置,免疫组化市场分为五个关键区域:北美、欧洲、亚洲太平洋、南太平洋中美洲、中东和非洲非洲。北美是免疫组化最大的市场,美国、加拿大和墨西哥是该地区市场的主要贡献者。北美市场的增长特点是癌症患病率不断上升以及癌症诊断工具的相应增长、免疫组织化学技术的进步以及老年人口的增加。此外,不断增长的医疗保健支出可能是北美免疫组化市场的主要增长刺激因素。

行业发展和未来机遇:

行业发展和未来机遇:

u>

全球免疫组织化学市场主要参与者采取的各种举措如下:

  1. 2021年7月,安捷伦科技公司的PD-L1 IHC 22C3 pharmDx扩大了非小细胞肺癌(NSCLC)的CE-IVD标志。在欧盟,它被标记为可长期用于非小细胞肺癌患者。现在可用于识别接受 Libtayo(cemiplimab)治疗且肿瘤 PD-L1 表达达到 50% 的 NSCLC 患者。
  2. 2020 年 4 月,Bio-Rad 推出了用于检测 Covid-19 的血液免疫测定试剂盒。它是一种基于血液的免疫测定试剂盒,用于识别 SARS-CoV-2(导致 Covid-19 的病毒)的抗体。
  3. 2020 年 9 月,Thermo Fisher 和 Humanigen 同意扩大规模生产针对 COVID-19 的单克隆抗体。这项业务交易预计将有助于扩大加州生物技术公司 lenlizumab 的生产规模,lenlizumab 是一种细胞因子风暴的临床阶段候选药物,该公司正在重症 COVID-19 患者中进行测试,以便于今年获得紧急使用批准。

    Covid-19 影响:

    COVID-19 大流行在北美对美国产生了重大影响。该国检测呈阳性的患者数量最多。全国各地的各个医疗保健研究中心只专注于 COVID 19 的治疗。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

    竞争格局和主要公司:

    全球免疫组织化学市场的一些知名企业包括 F. Hoffmann-LA Roche AG、Merck KGaA、PerkinElmer, Inc.、Thermo Fisher Scientific, Inc.、Abcam Plc、Agilent Technologies、Bio SB、Bio-Rad Laboratories、Cell Signaling Technology, Inc. 和 Danaher Corporation 等。这些公司专注于新产品的推出和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。它们拥有广泛的全球业务,这使它们能够为大量客户提供服务,从而增加其市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the most influencing segment growing in the immunohistochemistry market report??

Antibodies is the most influencing segment growing in the immunohistochemistry market.

What are the opportunities for new immunohistochemistry market entrants?

Development opportunities in emerging countries are likely to fuel the market growth in the comping years.

What are the key trends in the immunohistochemistry market?

Increasing acceptance of automation in immunohistochemistry is likely to act as trend the market growth in the comping years.

Which are the key players in the immunohistochemistry market?

Key players in the market are F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others.

What are the driving factors for the immunohistochemistry market across the globe?

Key factors driving the growth of the market are rising incidences of chronic and infectious diseases, increasing geriatric population, and increasing R&D investments by biotechnology & biopharmaceutical companies are among the key factors driving the market.

What is Immunohistochemistry?

Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.

Which region is lucrative for the immunohistochemistry market?

Asia-Pacific is the lucrative for the immunohistochemistry market.

The List of Companies - Immunohistochemistry Market

  1. F. Hoffmann-LA Roche AG
  2. Merck KGaA
  3. PerkinElmer, Inc.
  4. Thermo Fisher Scientific, Inc.
  5. Abcam Plc
  6. Agilent Technologies
  7. Bio SB
  8. Bio-Rad Laboratories
  9. Cell Signaling Technology, Inc.
  10. Danaher Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports